Company Filing History:
1 out of 1,745 
1 out of 7 
1 out of 58 
Years Active: 2024
Title: Innovations of Antoine Thierry in Ischemia Reperfusion Injury
Introduction
Antoine Thierry is a notable inventor based in Poitiers, France. He has made significant contributions to the field of medical research, particularly in understanding and preventing ischemia reperfusion injury (IRI). His innovative work has led to the development of methods that could potentially improve patient outcomes in organ transplantation and other medical scenarios.
Latest Patents
Antoine Thierry holds a patent for "Methods for preventing ischemia reperfusion injury in an organ with antibody antagonists of IL-33." This patent addresses the inflammation associated with IRI, which is characterized by leukocyte infiltration and renal tubular injury. The research identifies interleukin (IL)-33 as a key factor in tissue injury and the amplification of the innate immune response during kidney ischemia-reperfusion in experimental models. The findings suggest that antagonists of IL-33 could be used to mitigate the effects of IRI, thereby preserving renal function and reducing cellular injury.
Career Highlights
Throughout his career, Antoine Thierry has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the University Hospital Center of Poitiers (Centre Hospitalier Universitaire De Poitiers). His work has been pivotal in advancing the understanding of immune responses in organ injury.
Collaborations
Antoine Thierry has collaborated with notable colleagues, including André Herbelin and Jean-Marc Gombert. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his findings in the medical community.
Conclusion
Antoine Thierry's innovative work in the field of ischemia reperfusion injury showcases the importance of research in developing new therapeutic strategies. His contributions have the potential to significantly improve patient care in organ transplantation and related medical fields.